Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

NCT06914687 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Gastric Adenocarcinoma
Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma
Peritoneal Metastasis

Interventions

DRUG: Tislelizumab
DRUG: S-1
DRUG: Oxaliplatin
DRUG: Docetaxel
DRUG: Paclitaxel

Sponsor

Fudan University